Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p6
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 6/66)
Character Range: 15458–18409

hydrochloride)  Oral  APX-Ciprofloxacin  TY  MP NP  C5614 C5615 C5687 C5688 C5689 C5722 C5780     14  0     14

[44] Schedule 1, Part 1, entry for Ciprofloxacin in the form Tablet 750 mg (as hydrochloride)
omit:
Ciprofloxacin  Tablet 750 mg (as hydrochloride)  Oral  APX-Ciprofloxacin  TY  MP NP  C5614 C5615 C5687 C5688 C5689 C5722 C5780     14  0     14

[45] Schedule 1, Part 1, after entry for Citalopram in the form Tablet 10 mg (as hydrobromide) [Brand: Celapram; Maximum Quantity: 56; Number of Repeats: 2]
insert:
Citalopram  Tablet 10 mg (as hydrobromide)  Oral  CITALOPRAM-WGR  WG  MP NP  C4755   P4755   28  5     28
Citalopram  Tablet 10 mg (as hydrobromide)  Oral  CITALOPRAM-WGR  WG  MP NP  C15666  P15666  56  2     28

[46] Schedule 1, Part 1, after entry for Citalopram in the form Tablet 20 mg (as hydrobromide) [Brand: Citalopram Sandoz; Maximum Quantity: 56; Number of Repeats: 2]
insert:
Citalopram  Tablet 20 mg (as hydrobromide)  Oral  CITALOPRAM-WGR  WG  MP NP  C4755   P4755   28  5     28
Citalopram  Tablet 20 mg (as hydrobromide)  Oral  CITALOPRAM-WGR  WG  MP NP  C15666  P15666  56  2     28

[47] Schedule 1, Part 1, after entry for Citalopram in the form Tablet 40 mg (as hydrobromide) [Brand: Citalopram Sandoz; Maximum Quantity: 56; Number of Repeats: 2]
insert:
Citalopram  Tablet 40 mg (as hydrobromide)  Oral  CITALOPRAM-WGR  WG  MP NP  C4755   P4755   28  5     28
Citalopram  Tablet 40 mg (as hydrobromide)  Oral  CITALOPRAM-WGR  WG  MP NP  C15666  P15666  56  2     28

[48] Schedule 1, Part 1, entry for Dabigatran etexilate in the form Capsule 110 mg (as mesilate) [Brand: ARX-Dabigatran; Maximum Quantity: 120; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14308  substitute: C14301
(b) omit from the column headed "Purposes": P14308 substitute: P14301
[49] Schedule 1, Part 1, entry for Dabigatran etexilate in the form Capsule 110 mg (as mesilate) [Brand: Dabigatran Sandoz; Maximum Quantity: 120; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14308  substitute: C14301
(b) omit from the column headed "Purposes": P14308 substitute: P14301
[50] Schedule 1, Part 1, entry for Dabigatran etexilate in the form Capsule 110 mg (as mesilate) [Brand: PHARMACOR DABIGATRAN; Maximum Quantity: 120; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14308  substitute: C14301
(b) omit from the column headed "Purposes": P14308 substitute: P14301
[51] Schedule 1, Part 1, entry for Dabigatran etexilate in the form Capsule 110 mg (as mesilate) [Brand: Pradaxa; Maximum Quantity: 120; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14308  substitute: C14301
(b) omit from the column headed "Purposes": P14308 substitute: P14301
[52] Schedule 1, Part 1, entry for Dabigatran etexilate in the form Capsule 150 mg (as mesilate) [Brand: ARX-Dabigatran; Maximum Quantity: 120; Number of Repeats: 5]
(a) omit from the column